throbber
12/18/2014
`
`Tykerb | Tykerb.com
`
`Prescribing Information including BOXED WARNING (https://w w w .gsksource.com/gskprm/htdocs/documents/TYKERB­PI­PIL.PDF)
`Patient Information Leaflet (https://w w w .gsksource.com/gskprm/htdocs/documents/TYKERB­PI­PIL.PDF#nameddest=PIL)
`|
`Healthcare Professionals (https://w w w .gsksource.com/tykerb)
`IMPORTANT SAFETY INFORMATION
`
` |
` For US
`
` (/index.html)
`
`Some people may develop liver damage while taking TYKERB. Liver problems can be severe and deaths have
`happened. Before taking TYKERB, tell your doctor if you have liver problems. You may need a lower dose of TYKERB.
`Your doctor should do blood tests to check your liver before and during treatment with TYKERB.
`
`See full Important Safety Information below ▼
`
`TYKERB with Xeloda
`For HER2+ Metastatic 
`Breast Cancer
`
`TYKERB with Xeloda
`TYKERB is used with a medicine called Xeloda  (capecitabine) for

`the treatment of people with advanced or metastatic breast cancer
`whose tumors overexpress HER2, and who have received prior
`therapy including an anthracycline, a taxane, and Herceptin

`(trastuzumab). Tumors that are HER2 positive make a large amount
`of a protein called human epidermal growth factor receptor­2.
`
`TYKERB with Femara
`For HR+/HER2+
`Metastatic Breast Cancer
`
`TYKERB with Femara
`TYKERB is used with the medicine Femara  (letrozole) for the

`treatment of postmenopausal women with hormone receptor positive
`metastatic breast cancer that overexpresses the HER2 receptor for
`whom hormonal therapy is indicated.
`
` (/tykerb­xeloda/index.html)
`
` (/tykerb­femara/index.html)
`
`IMPORTANT SAFETY INFORMATION
`
`Some people may develop liver damage while taking TYKERB. Liver problems can be severe and deaths have happened. Before taking
`TYKERB, tell your doctor if you have liver problems. You may need a lower dose of TYKERB. Your doctor should do blood tests to check your liver
`before and during treatment with TYKERB. You should contact your doctor right away if you have itching, yellowing of your skin or the white part
`of your eyes, dark urine, pain or discomfort in the right upper stomach area.
`
`Do not take TYKERB if you are allergic to any of the ingredients in TYKERB.
`
`It is not known if TYKERB is safe and effective in children.
`
`Before taking TYKERB, tell your doctor if you have heart problems. Some people may develop heart problems while taking TYKERB, including decreased pumping
`of blood from the heart and an abnormal heartbeat. Call your doctor right away if you feel like your heart is pounding or racing; if you are dizzy, tired, or light­
`headed; or if you are short of breath. Your doctor should check your heart before and during treatment with TYKERB.
`
`Diarrhea is common with TYKERB and may sometimes be severe. Severe diarrhea can cause loss of fluid (dehydration) and some deaths have happened. Call
`your doctor right away if you have a change in bowel pattern or if you have severe diarrhea. Follow your doctor's instructions for what to do to help prevent or treat
`diarrhea.
`
`If you have a cough that will not go away or are short of breath, talk with your doctor. These may be signs of lung problems.
`
`Tell your doctor right away if you are or plan to become pregnant. You should not become pregnant when taking TYKERB because the unborn baby can be
`harmed. Tell your doctor if you are breastfeeding or plan to breastfeed. It is not known if TYKERB passes into breast milk. You and your doctor should decide if
`you will take TYKERB or breastfeed. You should not do both.
`
`http://www.tykerb.com/
`
`1/2
`
`IMMUNOGEN 2342, pg. 1
`Phigenix v. Immunogen
`IPR2014-00676
`
`

`

`12/18/2014
`
`Tykerb | Tykerb.com
`
`When TYKERB is taken with Xeloda or Femara, common side effects include diarrhea; red, painful hands and feet; nausea; rash; vomiting; feeling tired or weak;
`mouth sores; loss of appetite; indigestion; unusual hair loss or thinning; nosebleeds; headache; dry skin; itching; and nail disorders such as nail bed changes, nail
`pain, infection, and swelling of the cuticles.
`
`Tell your doctor about all the medicines you take, including prescription and over­the­counter medicines, vitamins, and herbal supplements. Do not eat or drink
`grapefruit products while taking TYKERB.
`
`Xeloda is a registered trademark of Roche Laboratories Inc.
`Herceptin is a registered trademark of Genentech, Inc.
`Femara is a registered trademark of Novartis Pharmaceuticals Corporation.
`
`Manage Communications (https://www.contactus.gsk.com/optout/index.html)
`
`You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, (http://www.fda.gov/Safety/MedWatch/default.htm) or call 1­
`800­FDA­1088.
`
` |  Privacy Statement
`Legal Notices (http://www.imgw.com/disclaimer.htm)
`(http://www.imgw.com/privacy.htm) 
`|  Medicine Savings (http://www.gskcta.com/) 
`|
`Contact Us (https://www.contactus.gsk.com/callback.html)
`
`This w ebsite is funded and developed by GSK. 
`This site is intended for US residents only. 
`©2014 GSK group of companies. All rights reserved.
`
`(http://www.gskcta.com/)
`
`(https://www.contactus.gsk.com/callback.html)
`
` (http://us.gsk.com)
`
`http://www.tykerb.com/
`
`2/2
`
`IMMUNOGEN 2342, pg. 2
`Phigenix v. Immunogen
`IPR2014-00676
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket